MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Avg target $247 (last qtr, 3 analysts) → $247 (last mo, 3) (+0.0%).
Buy-rated share 80% → 89% over ~3 months (+9pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.68 | $1.79 | +6.5% |
| Apr 2026 | $1.44 | $1.65 | +14.6% |
| Jan 2026 | $1.43 | $1.53 | +7.0% |
| Oct 2025 | $1.49 | $1.64 | +10.1% |
| Jul 2025 | $1.34 | $1.49 | +11.2% |
| Apr 2025 | $1.31 | $1.39 | +6.1% |
| Jan 2025 | $1.19 | $1.26 | +5.9% |
| Oct 2024 | $1.32 | $1.38 | +4.5% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 6.2%/yr (revenue basis).
Base free cash flow $256M (avg FY2023–FY2025; latest year $341M) · equity value $12.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B— | $1.8B-13.9% | $1.9B+4.8% | $2.1B+14.5% | $2.3B+8.2% |
| EPS (dil.) | $7.35— | $7.01-4.6% | $4.45-36.5% | $5.05+13.5% | $6.26+24.0% |
| Free Cash Flow | $463M— | -$509M-210.0% | $189Mn/m | $236M+24.8% | $341M+44.5% |
| Gross Margin | 33.4% | 37.2%+3.8pp | 40.3%+3.1pp | 40.7%+0.4pp | 42.2%+1.5pp |
| Operating Margin | 10.7% | 0.3%-10.4pp | 13.4%+13.1pp | 16.7%+3.2pp | 18.4%+1.7pp |
| Net Margin | 21.1% | 22.6%+1.5pp | 13.7%-8.8pp | 13.8%+0.1pp | 15.9%+2.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider $27K over 180 days (1 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 57 for Crane Company indicates a neutral outlook, with the stock's strengths and weaknesses balancing out. The stock scores high on risk, with a relatively low beta and volatility, but trades at a premium, as reflected in its value score, which is dragged down by a P/E of 37.9 and P/B of 5.8. Momentum and growth factors provide some support, driven by a 22.3% return over the past three months and 44.5% FCF growth, while profitability is a mixed bag, with an ROE of 16.2% and operating margin of 17.9%.